AtriCure, Inc. (ATRC) vs Dyne Therapeutics, Inc. (DYN)

A side-by-side comparison of AtriCure, Inc. and Dyne Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ATRC vs DYN

growth of $100 · dividends reinvested · last 6y
ATRC +36.7% (+5.3%/yr)DYN -35.4% (-7.0%/yr)ATRC compounded faster over this window
50100150200Start $100202120222023202420252026$137$65
ATRC DYN

ATRC vs DYN: by the numbers

  • •DYN is the larger company ($2.82B vs $2.78B market cap).
  • •ATRC is profitable (1.85% net margin) while DYN runs a net loss (0.00%).

Metrics side by side

Valuation

MetricATRCDYN
P/E ratio257.64N/A
P/S ratio4.88N/A
P/B ratio5.384.01
EV / EBITDA77.25N/A
FCF yield1.85%N/A

Profitability

MetricATRCDYN
Gross margin76.16%0.00%
Operating margin2.44%0.00%
Net margin1.85%0.00%
ROE2.04%-73.97%
ROIC2.04%-58.28%

Growth (annualized)

MetricATRCDYN
Revenue CAGR (5Y)18.57%N/A
Total return CAGR (5Y)-4.06%-0.38%

Frequently asked

Is ATRC or DYN more profitable?
ATRC runs the higher net margin — ATRC at 1.85% versus DYN at 0.00%.
How have ATRC and DYN total returns compared?
Over the past 5 years, ATRC delivered -4.06% and DYN delivered -0.38% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.